戻る Agenda
Session 7: Hot Topics
Session Chair(s)
Arthur A. Levin, PhD
Distinguished Scientist
Avidity Biosciences, United States
The hot topics session is designed to provide the attendees with a glimpse at future oligonucleotide therapeutics. This session is a chance to see how the field is developing and what kind of novel approaches or applications are being studied in academia and industry. With this early look at these approaches, it is hoped that the audience can envision the promise of new technologies and have a preview of the kind of challenges these technologies will face or pose to the current regulatory environment.
Speaker(s)
Speaker
Robert Ward
Eloxx Pharmaceuticals, United States
Chairman and CEO
Experience with FDA’s Complex Innovative Design (CID) Pilot
Jennifer Panagoulias, RAC
Consultant, United States
Regulatory Affairs and Compliance Consultant
Charles R Allerson, PhD
DTx Pharma, Inc., United States
VP of Chemistry and Drug Development
Potent siRNA Silencing in the Brain
Chantal Ferguson
University of Massachusetts Medical School, United States
MD/PhD Candidate
Daniele Merico
Deep Genomics Inc., Canada
Director of Molecular Genetics